4-month regimen of rifampin was not inferior to the 9-month regimen of isoniazid for the prevention

Two groundbreaking studies, one in adults and the other in children, have trialed a less toxic drug than Isonaizid for latent TB and cut the treatment time from nine months to four. Read the article from the New England Journal of Medicine here: https://www.nejm.org/doi/full/10.1056/NEJMoa1714283?query=featured_home